{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T23:22:09Z","timestamp":1777764129295,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872931"],"award-info":[{"award-number":["81872931"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073930"],"award-info":[{"award-number":["82073930"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274008"],"award-info":[{"award-number":["82274008"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173889,82274008,82073930"],"award-info":[{"award-number":["82173889,82274008,82073930"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173889"],"award-info":[{"award-number":["82173889"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.dmd.2025.100207","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T21:55:18Z","timestamp":1763762118000},"page":"100207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dual effects of a new CYP2E1 inhibitor on gout: Anti-inflammatory actions and lowered uric acid levels"],"prefix":"10.1016","volume":"54","author":[{"given":"Yong","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenxu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunchao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meidan","family":"Huo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linjing","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiwei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hailing","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4553-6258","authenticated-orcid":false,"given":"Na","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9711","key":"10.1016\/j.dmd.2025.100207_bib1","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0140-6736(09)60883-7","article-title":"Gout","volume":"375","author":"Richette","year":"2010","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.dmd.2025.100207_bib2","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1002\/acr.22585","article-title":"Study for updated gout classification criteria: identification of features to classify gout","volume":"67","author":"Taylor","year":"2015","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"13","key":"10.1016\/j.dmd.2025.100207_bib3","doi-asserted-by":"crossref","first-page":"6678","DOI":"10.3390\/ijms22136678","article-title":"The role of ABCG2 in the pathogenesis of primary hyperuricemia and gout\u2014an update","volume":"22","author":"Eckenstaler","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.dmd.2025.100207_bib4","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/s41584-020-0441-1","article-title":"Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors","volume":"16","author":"Dehlin","year":"2020","journal-title":"Nat Rev Rheumatol"},{"issue":"13","key":"10.1016\/j.dmd.2025.100207_bib5","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1056\/NEJMoa1710895","article-title":"Cardiovascular safety of febuxostat or allopurinol in patients with gout","volume":"378","author":"White","year":"2018","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.dmd.2025.100207_bib6","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1053\/j.ajkd.2017.01.055","article-title":"Management of gout and hyperuricemia in CKD","volume":"70","author":"Vargas-Santos","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.dmd.2025.100207_bib7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.maturitas.2018.10.012","article-title":"Gout\u2014an update of aetiology, genetics, co-morbidities and management","volume":"118","author":"Robinson","year":"2018","journal-title":"Maturitas"},{"issue":"11","key":"10.1016\/j.dmd.2025.100207_bib8","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.27421","article-title":"Estimation of primary prevention of gout in men through modification of obesity and other key lifestyle factors","volume":"3","author":"McCormick","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"7","key":"10.1016\/j.dmd.2025.100207_bib9","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s00296-014-3189-6","article-title":"Safety of allopurinol compared with other urate-lowering drugs in patients with gout: a systematic review and meta-analysis","volume":"35","author":"Castrejon","year":"2015","journal-title":"Rheumatol Int"},{"issue":"1","key":"10.1016\/j.dmd.2025.100207_bib10","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s13075-019-2011-y","article-title":"Acute kidney injury associated with febuxostat and allopurinol: a post-marketing study","volume":"21","author":"Rey","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.dmd.2025.100207_bib11","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev-physiol-021113-170343","article-title":"The molecular physiology of uric acid homeostasis","volume":"77","author":"Mandal","year":"2015","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.dmd.2025.100207_bib12","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.ijbiomac.2021.06.075","article-title":"Inhibitory mechanism of xanthine oxidase activity by caffeoylquinic acids in vitro","volume":"184","author":"Wan","year":"2021","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.dmd.2025.100207_bib13","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/5817348","article-title":"Research advances in the mechanisms of hyperuricemia-induced renal injury","volume":"2020","author":"Su","year":"2020","journal-title":"Biomed Res Int"},{"issue":"1","key":"10.1016\/j.dmd.2025.100207_bib14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s12325-014-0175-z","article-title":"A review of uric acid, crystal deposition disease, and gout","volume":"32","author":"Perez-Ruiz","year":"2015","journal-title":"Adv Ther"},{"issue":"1","key":"10.1016\/j.dmd.2025.100207_bib15","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41572-019-0115-y","article-title":"Gout","volume":"5","author":"Dalbeth","year":"2019","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"10.1016\/j.dmd.2025.100207_bib16","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3899\/jrheum.100727","article-title":"Radiographic bone damage in chronic gout is negatively associated with inflammatory cytokines soluble interleukin-6 receptor and osteoprotegerin","volume":"38","author":"Choe","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.dmd.2025.100207_bib17","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3389\/fphar.2020.00289","article-title":"Anti-hyperuricemic and anti-inflammatory effects of Marantodes pumilum as potential treatment for gout","volume":"11","author":"Rahmi","year":"2020","journal-title":"Front Pharmacol"},{"issue":"10","key":"10.1016\/j.dmd.2025.100207_bib18","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1007\/s10067-015-2933-y","article-title":"Molecular basis of oxidative stress in gouty arthropathy","volume":"34","author":"Zamudio-Cuevas","year":"2015","journal-title":"Clin Rheumatol"},{"issue":"22","key":"10.1016\/j.dmd.2025.100207_bib19","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1111\/j.1742-4658.2011.08357.x","article-title":"Mechanisms of mitochondrial targeting of cytochrome P450 2E1: physiopathological role in liver injury and obesity","volume":"278","author":"Knockaert","year":"2011","journal-title":"FEBS J"},{"issue":"5","key":"10.1016\/j.dmd.2025.100207_bib20","doi-asserted-by":"crossref","first-page":"L916","DOI":"10.1152\/ajplung.00144.2017","article-title":"CYP2E1 regulates the development of radiation-induced pulmonary fibrosis via ER stress- and ROS-dependent mechanisms","volume":"313","author":"Son","year":"2017","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"15","key":"10.1016\/j.dmd.2025.100207_bib21","doi-asserted-by":"crossref","first-page":"8221","DOI":"10.3390\/ijms22158221","article-title":"CYP2E1 in alcoholic and non-alcoholic liver injury: roles of ROS, reactive intermediates and lipid overload","volume":"22","author":"Harjum\u00e4ki","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.dmd.2025.100207_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2020.111937","article-title":"Allicin alleviates acrylamide-induced NLRP3 inflammasome activation via oxidative and ER stress in Kupffer cells and rat liver","volume":"148","author":"Nan","year":"2021","journal-title":"Food Chem Toxicol"},{"issue":"2","key":"10.1016\/j.dmd.2025.100207_bib23","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1080\/03602532.2019.1632889","article-title":"A comprehensive review of cytochrome P450 2E1 for xenobiotic metabolism","volume":"51","author":"Chen","year":"2019","journal-title":"Drug Metab Rev"},{"issue":"23","key":"10.1016\/j.dmd.2025.100207_bib24","article-title":"Identification of cytochrome P450 2E1 as a novel target in glioma and development of its inhibitor as an anti-tumor agent","volume":"10","author":"Hu","year":"2023","journal-title":"Adv Sci (Weinh)"},{"issue":"35","key":"10.1016\/j.dmd.2025.100207_bib25","article-title":"A novel cytochrome P450 2E1 inhibitor Q11 is effective on lung cancer via regulation of the inflammatory microenvironment","volume":"10","author":"Jia","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.dmd.2025.100207_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115638","article-title":"The CYP2E1 inhibitor Q11 ameliorates LPS-induced sepsis in mice by suppressing oxidative stress and NLRP3 activation","volume":"214","author":"Gao","year":"2023","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.dmd.2025.100207_bib27","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jconrel.2017.04.009","article-title":"Bioengineered robust hybrid hydrogels enrich the stability and efficacy of biological drugs","volume":"267","author":"Gil","year":"2017","journal-title":"J Control Release"},{"issue":"1","key":"10.1016\/j.dmd.2025.100207_bib28","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3390\/md11010099","article-title":"Soft coral\u2013derived lemnalol alleviates monosodium urate\u2013induced gouty arthritis in rats by inhibiting leukocyte infiltration and iNOS, COX-2 and c-Fos protein expression","volume":"11","author":"Lee","year":"2013","journal-title":"Mar Drugs"},{"issue":"1","key":"10.1016\/j.dmd.2025.100207_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053038","article-title":"Concentration-dependent inhibitory effect of baicalin on the plasma protein binding and metabolism of chlorzoxazone, a CYP2E1 probe substrate, in rats in vitro and in vivo","volume":"8","author":"Gao","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.dmd.2025.100207_bib30","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pharmthera.2018.02.011","article-title":"Inflammasome biology, molecular pathology and therapeutic implications","volume":"187","author":"Awad","year":"2018","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.dmd.2025.100207_bib31","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.freeradbiomed.2020.03.007","article-title":"Disulfiram suppresses NLRP3 inflammasome activation to treat peritoneal and gouty inflammation","volume":"152","author":"Deng","year":"2020","journal-title":"Free Radic Biol Med"},{"issue":"11","key":"10.1016\/j.dmd.2025.100207_bib32","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1177\/009127009903901110","article-title":"Effect of disulfiram-mediated CYP2E1 inhibition on the disposition of vesnarinone","volume":"39","author":"Frye","year":"1999","journal-title":"J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.dmd.2025.100207_bib33","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.apsb.2017.05.004","article-title":"Antihyperuricemic effect of mangiferin aglycon derivative J99745 by inhibiting xanthine oxidase activity and urate transporter 1 expression in mice","volume":"8","author":"Qin","year":"2018","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.dmd.2025.100207_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109195","article-title":"Curcumin attenuates potassium oxonate-induced hyperuricemia and kidney inflammation in mice","volume":"118","author":"Chen","year":"2019","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"10.1016\/j.dmd.2025.100207_bib35","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.freeradbiomed.2007.11.004","article-title":"CYP2E1 and oxidative liver injury by alcohol","volume":"44","author":"Lu","year":"2008","journal-title":"Free Radic Biol Med"},{"issue":"10","key":"10.1016\/j.dmd.2025.100207_bib36","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.bbamcr.2014.01.009","article-title":"The role of MAPK signalling pathways in the response to endoplasmic reticulum stress","volume":"1843","author":"Darling","year":"2014","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"10.1016\/j.dmd.2025.100207_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2021.152905","article-title":"Salidroside alleviates liver inflammation in furan-induced mice by regulating oxidative and endoplasmic reticulum stress","volume":"461","author":"Yuan","year":"2021","journal-title":"Toxicology"},{"key":"10.1016\/j.dmd.2025.100207_bib38","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bcp.2016.03.001","article-title":"Characterization of novel cytochrome P450 2E1 knockout rat model generated by CRISPR\/Cas9","volume":"105","author":"Wang","year":"2016","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"10.1016\/j.dmd.2025.100207_bib39","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/acr.24180","article-title":"2020 American College of Rheumatology guideline for the management of gout","volume":"72","author":"FitzGerald","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955625095169?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955625095169?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T14:59:00Z","timestamp":1777474740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955625095169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0090955625095169"],"URL":"https:\/\/doi.org\/10.1016\/j.dmd.2025.100207","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual effects of a new CYP2E1 inhibitor on gout: Anti-inflammatory actions and lowered uric acid levels","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmd.2025.100207","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100207"}}